Working… Menu

Activity & Safety Study of Lenalidomide & Rituximab as Non-chemotherapy Based Therapy on Chronic Lymphocytic Leukemia (LLC-LENAR-08)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01185262
Recruitment Status : Completed
First Posted : August 19, 2010
Last Update Posted : September 30, 2013
Celgene Corporation
Information provided by (Responsible Party):
MD Anderson International Spain SA

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : December 2012
Actual Study Completion Date : September 2013